Top Tweets for #NextGenLoading
At #ESMO26, we’re presenting the FOCUS-01 trial design and new preclinical data for AVA6103 (FAP-Exd), our first Next Gen pre|CISION® PDC, including activity in Enhertu®-resistant tumor models.
https://t.co/89dfmPg6j7 #preCISION #NextGenLoading #AVCT
We’re presenting the FOCUS-01 trial design and new preclinical data for AVA6103 (FAP-Exd) at the AACR Conference on Pancreatic Cancer.
https://t.co/baUM7yaam8
#PancreaticCancer #preCISION #AVCT #NextGenLoading
@tom_the_bomb__ At some point very soon, the wider market will realise that CC, RH and team are executing a very well thought out plan. #LetsDoThis #NextGenLoading #HopeWithoutCompromise #AVCT
Delighted to see #AVCT mentioned in the EndpointsNews round up. AVA6103 data this week were received well. Team are thrilled with the progress. FOCUS-01 Trial continues to escalate. #NextGenLoading
#LetsDoThis
https://t.co/l5JZGbQLh7
Here you will meet a number of folks on our team and understand the motivations behind their amazing work. Pleased to bring you our Wow Moments at #AVCT
#NextGenLoading
#LetsDoThis
Ask a scientist why they stay in oncology and you will usually hear about a "wow moment". The people behind pre|CISION® share theirs, from the first tumor to plasma data to a new molecule from idea to IND in 12 months. Watch the video here: https://t.co/yQYPRuyU6Y #AVCT
We are delighted to announce our proof of mechanism data with AVA6103. Our #AVCT team is working on making a dent in cancer. The versatility of the preCISION platform now allows us to access previously unaddressable markets.
#LetsDoThis
#NextGenLoading
#HopeWithoutCompromise
We have achieved clinical proof of mechanism for AVA6103 (FAP-Exd), our first Next Gen pre|CISION® PDC, in the Phase 1 FOCUS-01 trial. Clean safety profile through 3 dose levels, and clinical PK closely matches preclinical modeling.
https://t.co/IbI1P3XUPy
#NextGenLoading #AVCT
In episode 16 of the R&D Spotlight, the team discusses initial clinical data for AVA6103, pre|CISION® controlled-release exatecan, with two key clinical findings demonstrating proof of mechanism.
https://t.co/eDiCI7vNc6 #NextGenLoading #AVCT
We have achieved clinical proof of mechanism for AVA6103 (FAP-Exd), our first Next Gen pre|CISION® PDC, in the Phase 1 FOCUS-01 trial. Clean safety profile through 3 dose levels, and clinical PK closely matches preclinical modeling.
https://t.co/IbI1P3XUPy
#NextGenLoading #AVCT
When we talk about popular coaches.. it’s me a by a long shot..
bro the Jr Pios are hilarious.. they lined up waiting to ask the entire Varsity team to sign their gear 🤣😂🤣
#NextGenLoading
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers